Carlsmed
Carlsbad, US · Founded 2018 · Delaware corporation · 4 known investors
Carlsmed develops the aprevo personalized surgery platform for spine fusion procedures, producing patient-specific implants and technology used by spine surgeons. The company operates in the medical device industry with FDA-cleared lumbar and cervical fusion products.
AI & Machine LearningBiotechHardwareHealthtechMedical Devices
Founders & leadership
Carlsmed was founded in 2018 by Mike Cordonnier, Michael Cordonnier, and Niall Casey.
MC
Mike CordonnierCo-Founder, President & CEO
MC
Michael CordonnierCo-founder
NC
Niall CaseyCo-Founder & Chief Intellectual Property Officer
SH
Shariq HussainChief Technology Officer
AA
Alexander ArrowExecutive
SS
Sharon SchulzkiChief Clinical & Market Access Officer
LG
Leo GreensteinChief Financial Officer
JK
Jennifer KamocsayChief Legal Officer
SD
Scott DurallChief Commercial Officer
KS
Kevin SidowNamed on SEC filing
MS
Mark SingerNamed on SEC filing
Board
JR
Investors · 4
Competitors · 7
by search overlapGlobus Medical60 shared keywordsGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.
Rf Surgical56 shared keywordsMedtronic develops healthcare technology, including pulsed field ablation systems used to treat atrial fibrillation (AFib). The company serves clinicians and healthcare providers in the medical device and cardiac care field.
Massdevice45 shared keywordsMassDevice is a news and media outlet covering the medical device industry, publishing articles, special reports, and white papers on medtech companies, products, and regulatory topics such as FDA 510(k) submissions. It serves medical device professionals with industry news and analysis.
Alphatec Spine, Inc.42 shared keywordsATEC Spine develops surgical devices and approaches for spine surgery, targeting decompression, stabilization, and alignment for surgeons treating spinal pathologies. The company operates in the medical technology sector focused on spine surgery.
Read the Press Release38 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Orthoworld38 shared keywordsOrthoWorld publishes news and market analysis covering the orthopedic industry, including orthobiologics, implants, and surgical fixation systems. It reports on innovation pipelines, company performance, regulatory developments, acquisitions, and funding for professionals in the orthopedic medical device sector.
Cqmedical29 shared keywordsCQ Medical develops patient radiotherapy positioning products, including radiation immobilization masks and related devices used in cancer treatment and medical care. Formed in 2022 from the merger of legacy companies CIVCO RT and Qfix, it serves healthcare providers and patients in the radiotherapy field.
Companies competing with Carlsmed for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements$109.1M disclosed across 4 rounds · 2019–2024
▶$64.5MraisedFeb 2025 · 7 investors · OtherRule 506(b)
▶$64.5MraisedFeb 2025 · 7 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Robert MittendorffDirector
- Kevin O'BoyleDirector
- Leonard GreensteinExecutive Officer
- Durall ScottExecutive Officer
- Niall CaseyExecutive Officer, Director
- Philip YoungDirector
- Michael CordonnierExecutive Officer, Director
- Kevin SidowDirector
- Sharon SchulzkiExecutive Officer
- Shariq HussainExecutive Officer
- Jonathan RootDirector
- Offering amount
- $64.5M
- Amount sold
- $64.5M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30MraisedApr 2022 · 21 investors · BiotechnologyRule 506(b)
▶$30MraisedApr 2022 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin SidowDirector
- Shariq HussainExecutive Officer
- Alexander ArrowExecutive Officer
- Jonathan RootDirector
- Robert MittendorffDirector
- Sharon SchulzkiExecutive Officer
- Michael CordonnierExecutive Officer, Director
- Philip YoungDirector
- Mark SingerExecutive Officer
- Niall CaseyExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$12.6MraisedDec 2020 · 50 investors · BiotechnologyRule 506(b)
▶$12.6MraisedDec 2020 · 50 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alexander ArrowExecutive Officer
- Sharon SchulzkiExecutive Officer
- Niall CaseyExecutive Officer, Director
- Philip YoungDirector
- Kevin SidowDirector
- Shariq HussainExecutive Officer
- Justin EsterbergExecutive Officer
- Michael CordonnierExecutive Officer, Director
- Jonathon RootDirector
- Offering amount
- $12.6M
- Amount sold
- $12.6M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2MraisedMay 2020 · 40 investors · BiotechnologyRule 506(b)
▶$2MraisedMay 2020 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael CordonnierExecutive Officer, Director
- Jeffrey RohDirector
- Justin EsterbergExecutive Officer, Director
- Alexander ArrowExecutive Officer
- Sharon SchulzkiExecutive Officer
- Niall CaseyDirector
- Offering amount
- $2.5M
- Amount sold
- $2M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance - BioSpacebiospace.com · Aug 2026Frequently asked questions
- What does Carlsmed do?
- Carlsmed develops the aprevo personalized surgery platform for spine fusion procedures, producing patient-specific implants and technology used by spine surgeons. The company operates in the medical device industry with FDA-cleared lumbar and cervical fusion products.
- Who founded Carlsmed?
- Carlsmed was founded by Mike Cordonnier, Michael Cordonnier, Niall Casey in 2018.
- Who are Carlsmed's investors?
- Carlsmed's investors include B Capital Group, B4 Capital, US Venture Partners, Wavemaker Three-Sixty Health.
- How much funding has Carlsmed raised?
- Carlsmed has disclosed $109.1M raised across 4 rounds.
- Where is Carlsmed headquartered?
- Carlsmed is headquartered in Carlsbad, US.